- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Beijing Beilu Pharmaceutical (300016)
Beijing Beilu Pharmaceutical stock price live, this page displays SZ 300016 stock exchange data. View the 300016 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Beijing Beilu Pharmaceutical real time stock price chart below.
What Is the Beijing Beilu Pharmaceutical Stock Price Today?
The Beijing Beilu Pharmaceutical stock price today is 10.09.
What Is the Stock Symbol for Beijing Beilu Pharmaceutical?
The stock symbol for Beijing Beilu Pharmaceutical is ""300016.""
What Stock Exchange Does Beijing Beilu Pharmaceutical Trade On?
Beijing Beilu Pharmaceutical is listed and trades on the Shenzhen stock exchange.
Is Beijing Beilu Pharmaceutical a Good Stock to Buy?
Determining whether Beijing Beilu Pharmaceutical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300016 quote. (ISIN: CNE000001QK9)
What Is the Beijing Beilu Pharmaceutical Stock Price Today?
The Beijing Beilu Pharmaceutical stock price today is 10.09.
What Is the Stock Symbol for Beijing Beilu Pharmaceutical?
The stock symbol for Beijing Beilu Pharmaceutical is ""300016.""
What Stock Exchange Does Beijing Beilu Pharmaceutical Trade On?
Beijing Beilu Pharmaceutical is listed and trades on the Shenzhen stock exchange.
Is Beijing Beilu Pharmaceutical a Good Stock to Buy?
Determining whether Beijing Beilu Pharmaceutical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300016 quote. (ISIN: CNE000001QK9)
Shenzhen
Currency in CNY
10.09
+0.30(+3.06%)
Delayed Data·
Fair Value
An estimate of a Beijing Beilu Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.54
10.39
52 wk Range
4.38
10.97
300016 Scorecard
Full Analysis
Trading at a high earnings multiple
300016 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Beijing Beilu Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.5410.39
52 wk Range
4.3810.97
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.51%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.51%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
300016 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Beijing Beilu Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Beijing Beilu Pharmaceutical Company Profile
Beijing Beilu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. The company provides contrast agents, such as gadopentetate meglumine injection, gadobutrol injection, and gadobenate meglumine injection for MRI contrast; and iohexol injection, iopamidol injection, and iodixanol injection for CT contrast, as well as glimepiride and repaglinide tablets and jiuwei zhenxin granules. It also offers gadolinium-based agents, including gadopentetate dimeglumine and gadobutrol, as well as iodine-based agents comprising iohexol, ioversol, iodixanol, iopromide, and iopamidol, as well as oral anti-diabetic drugs. The company was founded in 1992 and is headquartered in Beijing, China.
Compare 300016 to Peers and Sector
Metrics to compare | 300016 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300016PeersSector | |
|---|---|---|---|---|
P/E Ratio | 312.4x | 33.3x | −0.5x | |
PEG Ratio | 2.57 | −0.78 | 0.00 | |
Price/Book | 3.1x | 3.3x | 2.6x | |
Price / LTM Sales | 4.9x | 6.2x | 3.3x | |
Upside (Analyst Target) | - | 8.5% | 41.6% | |
Fair Value Upside | Unlock | 2.4% | 5.9% | Unlock |
Earnings
Latest Release
May 30, 2025
EPS / Forecast
0.03 / --
Revenue / Forecast
282.68M / --
FAQ
What Stock Exchange Does Beijing Beilu Pharmaceutical Trade On?
Beijing Beilu Pharmaceutical is listed and trades on the Shenzhen Stock Exchange stock exchange.
What Is the Stock Symbol for Beijing Beilu Pharmaceutical?
The stock symbol for Beijing Beilu Pharmaceutical is "300016."
What Is the Beijing Beilu Pharmaceutical Market Cap?
As of today, Beijing Beilu Pharmaceutical market cap is 5.47B.
What Is Beijing Beilu Pharmaceutical's Earnings Per Share (TTM)?
The Beijing Beilu Pharmaceutical EPS (TTM) is 0.04.
When Is the Next Beijing Beilu Pharmaceutical Earnings Date?
Beijing Beilu Pharmaceutical will release its next earnings report on 22 Oct 2025.
From a Technical Analysis Perspective, Is 300016 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Beijing Beilu Pharmaceutical Stock Split?
Beijing Beilu Pharmaceutical has split 4 times.
How Many Employees Does Beijing Beilu Pharmaceutical Have?
Beijing Beilu Pharmaceutical has 1173 employees.
What is the current trading status of Beijing Beilu Pharmaceutical (300016)?
As of 13 Aug 2025, Beijing Beilu Pharmaceutical (300016) is trading at a price of 10.09, with a previous close of 9.79. The stock has fluctuated within a day range of 9.54 to 10.39, while its 52-week range spans from 4.38 to 10.97.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.